Di

All three found that in men with CAD, testosterone prolongs the time to exercise-induced ST-segment depression as measured on treadmill stress testing.24–26 Testosterone has been reported to have direct vasodilatory effects on coronary arteries in men with CAD.26 Whether low T and increased mortality are simply covariates or a causal relationship remains to be proven. 9 Finally, Corona et al. screened 1,178 articles and found 70 in their meta-analysis that showed a clear association between low T/high estradiol levels and CV disease.10 Longitudinal studies demonstrated that overall mortality and CV mortality were highest in those with low T levels. Some biological effects of testosterone may result from its aromatization to estradiol and subsequent interaction with the estrogen receptor. Only 1% to 2% of testosterone circulates in blood as unbound \"free\" testosterone, but this fraction exhibits the most potent biological activity. Testosterone (T) is the principal male sex hormone, secreted primarily by the testes and transported in the blood by the carrier protein, sex-hormone binding globulin (SHBG).
The authors also found higher vascular and all-cause mortality among men with low plasma T levels when compared with men without androgen deficiency. In lieu of such data, small randomized trials to date have been performed that evaluate CVD risk factors rather than events as study endpoints, and these demonstrate mixed effects of TRT. Testosterone prescriptions have risen steadily and sharply in the USA despite a lack of clear understanding of the relationship between androgens and cardiovascular disease. Finally, it is well known that the serum levels of Tes fall markedly with increasing age in otherwise normal men, and there is increasing evidence that Tes replacement therapy significantly improves cardiovascular and metabolic functions in hypogonadal aging men (28, 33, 34, 53, 62).
It is concerning, however, that there was a higher incidence of pulmonary embolism, atrial fibrillation, and acute kidney injury in the testosterone therapy group; this finding certainly warrants further evaluation. The TRAVERSE trial, reviewed here, was performed as a response to the Food and Drug Administration’s requirement in 2015 that manufacturers of testosterone replacement therapy conduct such trials. New research is required to understand the potential efficacy of androgen therapy, or lack thereof. Testosterone\'s major effect on vascular beds at physiologic concentrations remains unclear, with documentation of both vasodilatory and vasoconstrictive actions.
Flake et al52 determined the effects of sex hormones on inflammation of the temporomandibular joint in male and female rats. T lymphocytes, B lymphocytes, and macrophages can produce IL‐10; thus, more research was necessary to determine the source of the IL‐10 increase. In a similar study, Liva and Voskuhl49 examined male and female mice treated with DHT or placebo. Effects of Testosterone on Inflammation in Noncardiovascular Basic Science Models The sham‐castration group had a higher rupture and death rate, which also suggests that testosterone exacerbates the inflammatory response and the potential for cardiac rupture after MI.43
The relationship between low testosterone levels and diabetes mellitus (DM) may not depend on testosterone; it may be a result of poorly controlled DM. When exogenous testosterone administration was stopped for 2 weeks, an increase in insulin resistance, an important contributor to type 2 diabetes mellitus, was seen. Much evidence for the vasodilatory effects of testosterone exists, but less is known about the mechanism through which testosterone causes vasodilation. There was no difference in the concentration‐response curve of testosterone in vessels preconstricted with KCl instead of PGF.22 The ineffectiveness of endothelial denudation and flutamide incubation on relaxation percentages suggests that testosterone\'s vasodilatory effect is independent of both the endothelium and androgen receptors.
This was also seen in orchiectomized animals except in the epitestosterone group. This was not seen in castrated animals or intact animals subjected to epitestosterone administration. In vivo, coronary arterioles were examined using a Transonic perivascular flow meter, which is a device that is used to measure blood flow.